Current Opinion in Supportive and Palliative Care was launched in 2007. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of supportive and palliative care are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Miriam J. Johnson
Miriam J. Johnson, MD, FRCP, MRCP, MB ChB(hons), is Professor of Palliative Medicine at Hull York Medical School, Director of the Wolfson Palliative Care Research Centre, Co-Director of the Supportive Care, Early Diagnosis and Advanced Disease Research Group at the University of Hull and Director of the NIHR Academic Training Programme for East Yorkshire, UK. Her clinical and research interests include mechanisms and management of breathlessness and inequalities in palliative care service provision e.g. for people with non-malignant disease such as heart failure and respiratory disease. The projects employ a wide range of research methodologies (clinical trials of drug or complex interventions, qualitative studies, observational, secondary data analysis, data linkage studies) and collaborative partners are involved across different disciplines and countries. She has been published widely and holds grants from a variety of bodies (NIHR, NHMRC, Dunhill Medical Trust, Marie Curie Cancer Care/CRUK, Yorkshire Cancer Research, British Heart Foundation).
Professor Johnson is palliative care specialty joint lead for the Yorkshire and Humber Comprehensive Research Network. She set up one of the UK's first integrated palliative care services for people with heart failure.
David C. Currow
David C. Currow is Professor of Palliative Medicine at ImPACCT (Improving Palliative, Aged and Chronic Care through Clinical Research and Translation), Faculty of Health, University of Technology Sydney, Australia. He is Matthew Flinders Distinguished Professor of Palliative and Supportive Services at Flinders University, Adelaide. He is Associate Director of the Wolfson Palliative Care Research Centre, UK. His research track record includes: better understanding and treating chronic breathlessness; phase II, III and IV clinical trials; population-based planning for palliative care; and codifying the evidence base underpinning palliative care.
Professor Currow is the Principal Investigator for the Palliative Care Clinical Studies Collaborative (PaCCSC) which has randomised more than 1,800 palliative care patients across 23 sites to adequately powered and rigorously designed phase III symptom control studies. He is a foundation partner in the Australian Palliative Care Outcomes Collaborative (PCOC), an initiative to improve systematically clinical outcomes in palliative care. Competitive funding has included the National Health and Medical Research Council (NHMRC) and the National Institutes of Health (NIH).
David has published more than 480 peer-reviewed articles, editorials and books. He is an Editor on the 5th edition of the Oxford Textbook of Palliative Medicine. He is Senior Associate Editor of Journal of Palliative Medicine and on the editorial boards of Journal of Pain and Symptom Management, BMJ Supportive and Palliative Care and the Journal of Oncology Practice. David is a former president of Palliative Care Australia and the Clinical Oncological Society of Australia.
Diana M. Greenfield
Professor Diana M. Greenfield, PhD, RN, is Macmillan Consultant Nurse in Late Effects at Sheffield Teaching Hospitals NHS Foundation Trust, and Honorary Professor in Cancer Survivorship, Department of Oncology and Metabolism, University of Sheffield, UK. Diana leads an award-winning multi-disciplinary team providing late effects care for people after cancer and after bone marrow transplant. This service was awarded the prestigious Health Service Journal and Nursing Times Patient Safety and Care Award in the Cancer Care category in 2014. Additionally, Diana was awarded ‘Inspirational Leader’ in the NHS Regional Leadership Awards for Yorkshire and Humber in 2014 and was a finalist in the national awards in 2015. More recently, Diana was short-listed for an Innovation Excellence award for Macmillan Professionals.
Academically, Diana's research interests include late effects of cancer therapy including metabolic syndrome, models of follow-up care, and promoting and sustaining recovery in cancer patients including the cumulative burden of people living with both late effects and advanced disease. In addition to numerous peer-reviewed scientific publications, Diana has published a number of late effects guidelines and workforce initiatives such as competency frameworks for nurses and allied health professionals. She is currently leading a study examining workforce readiness in promoting physical activity to patients with cancer, and she is co-investigator on a number of collaborative studies concerning optimising the health and well-being of cancer patients. Collegiate activities include the Macmillan Research Advisory Panel, Member of the NCRI Clinical Studies sub group ‘understanding and measuring the consequences of cancer and its treatment’, and Lead Nurse on the Complications and Quality of Life Working Party for the European Bone Marrow Transplant Group.
Diana strives to develop and improve aftercare services for all cancer patients both within her own hospital trust and through regional and national initiatives. For instance, Diana is an active member of both a Macmillan supported ‘Community of Influence’ and the Consequences of Cancer Collaborative (CCAT), and is Lead Clinician on the Executive Board of the regional Living With and Beyond Cancer Programme. She is also part of the Working Together Partnership and a member of the project board of a virtual late effects multidisciplinary team national pilot for people affected by cancer, funded by Macmillan Cancer Support. She is a clinical advisor to a number of national and local patient charities, including Macmillan Cancer Support, Anthony Nolan and Cavendish Cancer Care. Diana is a Trustee of St Luke's Hospice, Sheffield.
Fred Saad, MD, FRCS, is Full Professor and Chief of Urology and Director of G-U Oncology at the University of Montreal Hospital Centers (CHUM), Canada. He holds the U of M Endowed Chair in Prostate Cancer Research and is Director of the molecular oncology research lab in Prostate Cancer. He is the past Chair of the National Cancer Institute of Canada G-U Group and the Canadian Urologic Oncology Group.
Dr Saad has been involved in most of the important clinical trials in advanced prostate cancer over the last 20 years and presently sits on 7 steering committees of international clinical trials. He serves on several international guidelines committees and sits on 7 editorial boards, including Lancet Oncology, JAMA Oncology, Nature Urology, and Urology as well as Current Oncology. He has published 350 peer-reviewed articles with over 32,000 citations, as well as over 1000 scientific abstracts, 8 books and over 50 book chapters. Dr Saad's research interests include molecular prognostic markers, mechanisms of progression, and new therapeutics in prostate cancer. He has over 40 clinical and basic research projects ongoing and has received over 30 million dollars in research grants to date. In 2014 he received the lifetime achievement award for research from the CHUM Research Center.